The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate communication and behavioral strategies in individuals with syndromic intellectual and developmental disorders.
Participants will be asked to complete virtual study assessments at intake and then on a monthly basis for the duration of 3-6 months. In addition, participants will attend weekly or biweekly virtual intervention visits with a study therapist.
Age(s) 2-12 years old at time of enrollment
Existing genetic syndrome based on clinical or genetic diagnosis and confirmed by medical records
Documented diagnosis of global developmental delay (GDD) or intellectual disability (ID)
estimated ID in all ranges
High levels of aggression that mitigate remote or outpatient treatment as defined by clinician judgement and/or ABC Irritability scores above 20 (i.e., higher level of care needed than provided by study procedures)
Medical or psychiatric instability that may limit study participation
Meaningful change in medication or psychosocial interventions 3 months prior to baseline visit
Limitations in technology access that may hinder participation in remote trial (e.g., declining support provided by study participation)
Rush University Medical Center
Lead sponsor
Emory University
Collaborator